Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BlackRidge Technology was a cybersecurity firm that specialized in identity-based network security and cloaking technology for enterprise and industrial networks. The company's core offering was its patented Transport Access Control (TAC) platform, which authenticated users and devices at the network layer before allowing any communication to occur. Within the healthcare sector, BlackRidge focused on securing the Internet of Medical Things (IoMT), providing protection for connected medical devices and hospital information systems against unauthorized access and cyber threats. By authenticating identities before a network session was established, the technology aimed to prevent data breaches and ensure the integrity of sensitive clinical environments. Despite its innovative approach to zero-trust security, the company faced significant financial challenges and filed for Chapter 11 bankruptcy in 2020.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BlackRidge Technology.